| Rhodanine as a privileged scaffold in drug discovery T Tomasic, LP Masic Current Medicinal Chemistry 16 (13), 1596-1629, 2009 | 345 | 2009 |
| Bioactivation potential of thiophene-containing drugs D Gramec, L Peterlin Mašič, M Sollner Dolenc Chemical research in toxicology 27 (8), 1344-1358, 2014 | 252 | 2014 |
| Bisphenol A and its analogs: Do their metabolites have endocrine activity? DG Skledar, LP Mašič Environmental toxicology and pharmacology 47, 182-199, 2016 | 217 | 2016 |
| Rhodanine as a scaffold in drug discovery: a critical review of its biological activities and mechanisms of target modulation T Tomašić, L Peterlin Mašič Expert opinion on drug discovery 7 (7), 549-560, 2012 | 194 | 2012 |
| Efflux pump inhibitors of clinically relevant multidrug resistant bacteria A Lamut, L Peterlin Mašič, D Kikelj, T Tomašič Medicinal Research Reviews 39 (6), 2460-2504, 2019 | 170 | 2019 |
| Mutagenicity and DNA damage of bisphenol A and its structural analogues in HepG2 cells A Fic, M Sollner Dolenc, M Filipič, L Peterlin Mašić Arhiv za higijenu rada i toksikologiju 64 (2), 189-199, 2013 | 149 | 2013 |
| Arginine mimetics L Peterlin-Mašič, D Kikelj Tetrahedron 57 (33), 7073-7105, 2001 | 145 | 2001 |
| Discovery of benzothiazole scaffold-based DNA gyrase B inhibitors M Gjorgjieva, T Tomasic, M Barancokova, S Katsamakas, J Ilas, ... Journal of medicinal chemistry 59 (19), 8941-8954, 2016 | 136 | 2016 |
| Discovery of 4,5,6,7-Tetrahydrobenzo[1,2-d]thiazoles as Novel DNA Gyrase Inhibitors Targeting the ATP-Binding Site T Tomasic, S Katsamakas, Z Hodnik, J Ilaš, M Brvar, T Solmajer, ... Journal of medicinal chemistry 58 (14), 5501-5521, 2015 | 130 | 2015 |
| Prospects for developing new antibacterials targeting bacterial type IIA topoisomerases T Tomašić, L Peterlin Masic Current topics in medicinal chemistry 14 (1), 130-151, 2014 | 130 | 2014 |
| Discovery of novel 5-benzylidenerhodanine and 5-benzylidenethiazolidine-2, 4-dione inhibitors of MurD ligase N Zidar, T Tomašić, R Šink, V Rupnik, A Kovac, S Turk, D Patin, ... Journal of medicinal chemistry 53 (18), 6584-6594, 2010 | 127 | 2010 |
| Physiologically based pharmacokinetic (PBPK) modeling of the bisphenols BPA, BPS, BPF, and BPAF with new experimental metabolic parameters: comparing the pharmacokinetic … C Karrer, T Roiss, N von Goetz, D Gramec Skledar, L Peterlin Mašič, ... Environmental health perspectives 126 (7), 077002, 2018 | 115 | 2018 |
| Bioactivation of bisphenol A and its analogs (BPF, BPAF, BPZ and DMBPA) in human liver microsomes J Schmidt, P Kotnik, J Trontelj, Ž Knez, LP Mašič Toxicology in vitro 27 (4), 1267-1276, 2013 | 109 | 2013 |
| Influence of metabolism on endocrine activities of bisphenol S DG Skledar, J Schmidt, A Fic, I Klopčič, J Trontelj, MS Dolenc, M Finel, ... Chemosphere 157, 152-159, 2016 | 104 | 2016 |
| 5‐Benzylidenethiazolidin‐4‐ones as multitarget inhibitors of bacterial Mur ligases T Tomašić, N Zidar, A Kovač, S Turk, M Simčič, D Blanot, ... ChemMedChem: Chemistry Enabling Drug Discovery 5 (2), 286-295, 2010 | 95 | 2010 |
| Synthesis and antibacterial activity of 5-ylidenethiazolidin-4-ones and 5-benzylidene-4, 6-pyrimidinediones T Tomašić, N Zidar, M Mueller-Premru, D Kikelj, LP Mašič European Journal of Medicinal Chemistry 45 (4), 1667-1672, 2010 | 87 | 2010 |
| In silico discovery of 2-amino-4-(2, 4-dihydroxyphenyl) thiazoles as novel inhibitors of DNA gyrase B M Brvar, A Perdih, M Oblak, LP Mašič, T Solmajer Bioorganic & Medicinal Chemistry Letters 20 (3), 958-962, 2010 | 82 | 2010 |
| Estrogenic and androgenic activities of TBBA and TBMEPH, metabolites of novel brominated flame retardants, and selected bisphenols, using the XenoScreen XL YES/YAS assay A Fic, B Žegura, D Gramec, LP Mašič Chemosphere 112, 362-369, 2014 | 78 | 2014 |
| Antimicrobial activity of the marine alkaloids, clathrodin and oroidin, and their synthetic analogues N Zidar, S Montalvão, Ž Hodnik, DA Nawrot, A Žula, J Ilaš, D Kikelj, ... Marine drugs 12 (2), 940-963, 2014 | 75 | 2014 |
| Arginine mimetic structures in biologically active antagonists and inhibitors L Peterlin Masic Current medicinal chemistry 13 (30), 3627-3648, 2006 | 75 | 2006 |
Tihomir TomasicUniversity of Ljubljana, Faculty of PharmacyEmail verificata su ffa.uni-lj.si